These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3284115)

  • 1. Transdermal application of cyclosporine prolongs skin allograft survival.
    Black KS; Hewitt CW; Chau CL; Pizzo L
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):660-2. PubMed ID: 3284115
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine dosage requirements for rabbit skin allograft enhancement due to perioperative blood transfusion and cyclosporine synergy.
    Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2895-7. PubMed ID: 3551232
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin.
    Jolley WB; Sharma B; Chami R; Ng C; Bullington R
    Transplant Proc; 1988 Aug; 20(4):703-6. PubMed ID: 3043841
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimization by timing of oral cyclosporine to prevent acute kidney allograft rejection in dogs.
    Cavallini M; Halberg F; Sutherland DE; Cornélissen G; Heil J; Najarian JS
    Transplantation; 1986 May; 41(5):654-7. PubMed ID: 3518168
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic activity of cyclosporine metabolites.
    Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VM
    Transplant Proc; 1990 Jun; 22(3):1129-34. PubMed ID: 2349673
    [No Abstract]   [Full Text] [Related]  

  • 8. The prolongation of skin allograft survival by topical use of cyclosporine A.
    Zhao XF; Schroeder TJ; Alexander JW; Miskell P; Gonce SJ; Babcock GF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):670-3. PubMed ID: 3284116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18.
    DiStefano R; Kupiec-Weglinski JW; Uhteg LC; Puskas J; Araneda D; Diamantstein T; Tilney NL
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):217-22. PubMed ID: 3129842
    [No Abstract]   [Full Text] [Related]  

  • 10. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different parameters for the monitoring of cyclosporine.
    Humbert H; Vernillet L; Cabiac MD; Barradas J; Billaud E
    Transplant Proc; 1990 Jun; 22(3):1210-5. PubMed ID: 2349682
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indefinite survival of pancreatic allografts under cyclosporin A treatment in rats].
    Domergue J; Bouhaddioui N; Barneon G; Marchal G
    J Chir (Paris); 1984 Mar; 121(3):195-201. PubMed ID: 6373804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of long-surviving mouse skin allografts after withdrawal of cyclosporin A therapy.
    Lems SP; Capel PJ; Koene RA
    Transplant Proc; 1980 Jun; 12(2):283-6. PubMed ID: 6994296
    [No Abstract]   [Full Text] [Related]  

  • 14. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
    J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival.
    Thomas J; Whitley T; Carver M; Thomas F
    Transplant Proc; 1984 Dec; 16(6):1522-4. PubMed ID: 6390858
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract]   [Full Text] [Related]  

  • 17. Rabbit corneal allograft survival following topical administration of cyclosporin A.
    Kana JS; Hoffmann F; Buchen R; Krolik A; Wiederholt M
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):686-90. PubMed ID: 7076412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic administration of Chlorambucil and topical application of Cyclosporin A on corneal graft survival in rabbits.
    Levinger S; Zauberman H
    Isr J Med Sci; 1985 Aug; 21(8):670-4. PubMed ID: 3899991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.